Dr. Lal Path Labs News
- Market cap
- ₹32,569 crore
- P/E
- 60.1
- P/B
- 12.99
- ROE
- 21.6%
- Dividend yield
- 0.46%
The latest update on Dr. Lal Path Labs is "LALPATHLAB Reports Quarterly Financial Results & Operating Metrics Update" (BSE Corporate Announcement), published 7 October 2026. This page lists 4 recent headlines and exchange announcements, 2 of them filed on BSE.
Latest Dr. Lal Path Labs news and announcements
- LALPATHLAB Reports Quarterly Financial Results & Operating Metrics Update
- Market Wrap: LALPATHLAB Shares Trade Higher Following Positive Sector Sentiment
- LALPATHLAB Board Approves Strategic Growth Initiatives & Governance Filings
- Analyst Commentary: Institutional Investors Review LALPATHLAB Long-Term Outlook
Source: Publisher headlines and announcements filed on BSE, linked to their original sources. Data as of 7 October 2026. How this data is compiled.
Dr. Lal Path Labs news & announcements — frequently asked questions
What is the latest news on Dr. Lal Path Labs?
The most recent item is "LALPATHLAB Reports Quarterly Financial Results & Operating Metrics Update" from BSE Corporate Announcement on 7 October 2026. The full list above links to each original source.
Where do these Dr. Lal Path Labs headlines come from?
Headlines link to the original publisher, and exchange announcements link to the filing on BSE. ATS lists them by date and does not rewrite or summarise them.
Same Data For Peers
Trade Dr. Lal Path Labs With ATS
Track LALPATHLAB live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.